The Role of Anti-LeY Antibody in the Downregulation of MAPKs/COX-2 Pathway in Gastric Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|15|4|469-476

ISSN： 1389-4501

Source： Current Drug Targets, Vol.15, Iss.4, 2014-04, pp. : 469-476

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Involvement of Nuclear Factor κB (NF-κB) in the Downregulation of Cyclooxygenase-2 (COX-2) by Genistein in Gastric Cancer Cells

By Li Y-S   Wu L-P   Li K-H   Liu Y-P   Xiang R   Zhang S-B   Zhu L-Y   Zhang L-Y  

The Journal of International Medical Research, Vol. 39, Iss. 6, 2011-11 ,pp. : 2141-2150

Field House Publishing

Access to resources Recommend Favorite

The role of COX-2 in intestinal cancer

By Williams C.S.   Shattuck-Brandt R.L.   DuBois R.N.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 1, 1999-01 ,pp. : 1-12

Informa Healthcare

Access to resources Recommend Favorite

The Role of COX-2 in Oral Cancer Development, and Chemoprevention/ Treatment of Oral Cancer by Selective COX-2 Inhibitors

By  

Current Pharmaceutical Design, Vol. 11, Iss. 14, 2005-05 ,pp. : 1771-1777

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of COX-1 and COX-2 in Alzheimer's Disease Pathology and the Therapeutic Potentials of Non-Steroidal Anti-Inflammatory Drugs

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 4, Iss. 3, 2005-06 ,pp. : 307-315

Bentham Science Publishers

Access to resources Recommend Favorite

Bid Mediates Anti-Apoptotic COX-2 Induction Through the IKK&bgr;/NF&kgr;B Pathway Due to 5-MCDE Exposure

By  

Current Cancer Drug Targets, Vol. 10, Iss. 1, 2010-02 ,pp. : 96-106

Bentham Science Publishers

Access to resources Recommend Favorite